 | • レポートコード：MRC2312MG03409 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学＆材料 |
| Single User | ￥468,000 (USD3,250) | ▷ お問い合わせ |
| Multi User | ￥608,400 (USD4,225) | ▷ お問い合わせ |
| Enterprise User | ￥702,000 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Global Biological Pentylenediamine for Medicine Market 調査レポートは次の情報を含め、グローバルにおけるの医療用生物学的ペンチレンジアミン市場規模と予測を収録しています。 ・世界の医療用生物学的ペンチレンジアミン市場：売上、2018年-2023年、2024年-2029年 ・世界の医療用生物学的ペンチレンジアミン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の医療用生物学的ペンチレンジアミン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「純度98.5%-99%」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。 医療用生物学的ペンチレンジアミンのグローバル主要企業は、Cathay Biotech、 Aphena Pharma Solutions、 Bio-Tech Pharmacal、 Goodwin Biotechnology、 Xenon Pharmaceuticals、 Nektar Therapeutics、 Midas Pharmaceuticals、 Kedrion Biopharma、 Xcelthera、 Anichem、 ALC Bio Innovations、 ACADIA Pharmaceuticals、 AbbVie、 Ology Bioservices、 QMI - Quality Management、 Biomiga、 Molecular Targeting Technologiesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル社は、医療用生物学的ペンチレンジアミンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別マーケット分析】 世界の医療用生物学的ペンチレンジアミン市場：タイプ別、2018年-2023年、2024年-2029年 世界の医療用生物学的ペンチレンジアミン市場：タイプ別市場シェア、2022年 ・純度98.5%-99%、純度≧99% 世界の医療用生物学的ペンチレンジアミン市場：用途別、2018年-2023年、2024年-2029年 世界の医療用生物学的ペンチレンジアミン市場：用途別市場シェア、2022年 ・製薬、医療研究、その他 世界の医療用生物学的ペンチレンジアミン市場：地域・国別、2018年-2023年、2024年-2029年 世界の医療用生物学的ペンチレンジアミン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競争分析】 また、当レポートは主要な参入企業の分析を提供します。 ・主要企業における医療用生物学的ペンチレンジアミンのグローバル売上、2018年-2023年 ・主要企業における医療用生物学的ペンチレンジアミンのグローバル売上シェア、2022年 ・主要企業における医療用生物学的ペンチレンジアミンのグローバル販売量、2018年-2023年 ・主要企業における医療用生物学的ペンチレンジアミンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業の情報を提示します。 Cathay Biotech、 Aphena Pharma Solutions、 Bio-Tech Pharmacal、 Goodwin Biotechnology、 Xenon Pharmaceuticals、 Nektar Therapeutics、 Midas Pharmaceuticals、 Kedrion Biopharma、 Xcelthera、 Anichem、 ALC Bio Innovations、 ACADIA Pharmaceuticals、 AbbVie、 Ology Bioservices、 QMI - Quality Management、 Biomiga、 Molecular Targeting Technologies ************************************************************* ・調査・分析レポートの概要 医療用生物学的ペンチレンジアミン市場の定義 市場セグメント 世界の医療用生物学的ペンチレンジアミン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の医療用生物学的ペンチレンジアミン市場規模 世界の医療用生物学的ペンチレンジアミン市場規模：2022年 VS 2029年 世界の医療用生物学的ペンチレンジアミン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの医療用生物学的ペンチレンジアミンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の医療用生物学的ペンチレンジアミン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：純度98.5%-99%、純度≧99% 医療用生物学的ペンチレンジアミンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：製薬、医療研究、その他 医療用生物学的ペンチレンジアミンの用途別グローバル売上・予測 ・地域別市場分析 地域別医療用生物学的ペンチレンジアミン市場規模 2022年と2029年 地域別医療用生物学的ペンチレンジアミン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど） Cathay Biotech、 Aphena Pharma Solutions、 Bio-Tech Pharmacal、 Goodwin Biotechnology、 Xenon Pharmaceuticals、 Nektar Therapeutics、 Midas Pharmaceuticals、 Kedrion Biopharma、 Xcelthera、 Anichem、 ALC Bio Innovations、 ACADIA Pharmaceuticals、 AbbVie、 Ology Bioservices、 QMI - Quality Management、 Biomiga、 Molecular Targeting Technologies ... |
This research report provides a comprehensive analysis of the Biological Pentylenediamine for Medicine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Biological Pentylenediamine for Medicine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Biological Pentylenediamine for Medicine, challenges faced by the industry, and potential opportunities for market players.
The global Biological Pentylenediamine for Medicine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Biological Pentylenediamine for Medicine market presents opportunities for various stakeholders, including Pharmaceutical Industry, Medical Research. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Biological Pentylenediamine for Medicine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Biological Pentylenediamine for Medicine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Biological Pentylenediamine for Medicine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Biological Pentylenediamine for Medicine market.
Market Overview: The report provides a comprehensive overview of the Biological Pentylenediamine for Medicine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Purity 98.5%-99%, Purity ≥99%), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Biological Pentylenediamine for Medicine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Biological Pentylenediamine for Medicine market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Biological Pentylenediamine for Medicine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Biological Pentylenediamine for Medicine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Biological Pentylenediamine for Medicine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Biological Pentylenediamine for Medicine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Biological Pentylenediamine for Medicine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Biological Pentylenediamine for Medicine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Biological Pentylenediamine for Medicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Purity 98.5%-99%
Purity ≥99%
Market segment by Application
Pharmaceutical Industry
Medical Research
Others
Global Biological Pentylenediamine for Medicine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Cathay Biotech
Aphena Pharma Solutions
Bio-Tech Pharmacal
Goodwin Biotechnology
Xenon Pharmaceuticals
Nektar Therapeutics
Midas Pharmaceuticals
Kedrion Biopharma
Xcelthera
Anichem
ALC Bio Innovations
ACADIA Pharmaceuticals
AbbVie
Ology Bioservices
QMI – Quality Management
Biomiga
Molecular Targeting Technologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biological Pentylenediamine for Medicine, market overview.
Chapter 2: Global Biological Pentylenediamine for Medicine market size in revenue and volume.
Chapter 3: Detailed analysis of Biological Pentylenediamine for Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biological Pentylenediamine for Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biological Pentylenediamine for Medicine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Biological Pentylenediamine for Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biological Pentylenediamine for Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biological Pentylenediamine for Medicine Overall Market Size
2.1 Global Biological Pentylenediamine for Medicine Market Size: 2022 VS 2029
2.2 Global Biological Pentylenediamine for Medicine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Biological Pentylenediamine for Medicine Sales: 2018-2029
3 Company Landscape
3.1 Top Biological Pentylenediamine for Medicine Players in Global Market
3.2 Top Global Biological Pentylenediamine for Medicine Companies Ranked by Revenue
3.3 Global Biological Pentylenediamine for Medicine Revenue by Companies
3.4 Global Biological Pentylenediamine for Medicine Sales by Companies
3.5 Global Biological Pentylenediamine for Medicine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Biological Pentylenediamine for Medicine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Biological Pentylenediamine for Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biological Pentylenediamine for Medicine Players in Global Market
3.8.1 List of Global Tier 1 Biological Pentylenediamine for Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Biological Pentylenediamine for Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Biological Pentylenediamine for Medicine Market Size Markets, 2022 & 2029
4.1.2 Purity 98.5%-99%
4.1.3 Purity ≥99%
4.2 By Type – Global Biological Pentylenediamine for Medicine Revenue & Forecasts
4.2.1 By Type – Global Biological Pentylenediamine for Medicine Revenue, 2018-2023
4.2.2 By Type – Global Biological Pentylenediamine for Medicine Revenue, 2024-2029
4.2.3 By Type – Global Biological Pentylenediamine for Medicine Revenue Market Share, 2018-2029
4.3 By Type – Global Biological Pentylenediamine for Medicine Sales & Forecasts
4.3.1 By Type – Global Biological Pentylenediamine for Medicine Sales, 2018-2023
4.3.2 By Type – Global Biological Pentylenediamine for Medicine Sales, 2024-2029
4.3.3 By Type – Global Biological Pentylenediamine for Medicine Sales Market Share, 2018-2029
4.4 By Type – Global Biological Pentylenediamine for Medicine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Biological Pentylenediamine for Medicine Market Size, 2022 & 2029
5.1.2 Pharmaceutical Industry
5.1.3 Medical Research
5.1.4 Others
5.2 By Application – Global Biological Pentylenediamine for Medicine Revenue & Forecasts
5.2.1 By Application – Global Biological Pentylenediamine for Medicine Revenue, 2018-2023
5.2.2 By Application – Global Biological Pentylenediamine for Medicine Revenue, 2024-2029
5.2.3 By Application – Global Biological Pentylenediamine for Medicine Revenue Market Share, 2018-2029
5.3 By Application – Global Biological Pentylenediamine for Medicine Sales & Forecasts
5.3.1 By Application – Global Biological Pentylenediamine for Medicine Sales, 2018-2023
5.3.2 By Application – Global Biological Pentylenediamine for Medicine Sales, 2024-2029
5.3.3 By Application – Global Biological Pentylenediamine for Medicine Sales Market Share, 2018-2029
5.4 By Application – Global Biological Pentylenediamine for Medicine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Biological Pentylenediamine for Medicine Market Size, 2022 & 2029
6.2 By Region – Global Biological Pentylenediamine for Medicine Revenue & Forecasts
6.2.1 By Region – Global Biological Pentylenediamine for Medicine Revenue, 2018-2023
6.2.2 By Region – Global Biological Pentylenediamine for Medicine Revenue, 2024-2029
6.2.3 By Region – Global Biological Pentylenediamine for Medicine Revenue Market Share, 2018-2029
6.3 By Region – Global Biological Pentylenediamine for Medicine Sales & Forecasts
6.3.1 By Region – Global Biological Pentylenediamine for Medicine Sales, 2018-2023
6.3.2 By Region – Global Biological Pentylenediamine for Medicine Sales, 2024-2029
6.3.3 By Region – Global Biological Pentylenediamine for Medicine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Biological Pentylenediamine for Medicine Revenue, 2018-2029
6.4.2 By Country – North America Biological Pentylenediamine for Medicine Sales, 2018-2029
6.4.3 US Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.4.4 Canada Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.4.5 Mexico Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Biological Pentylenediamine for Medicine Revenue, 2018-2029
6.5.2 By Country – Europe Biological Pentylenediamine for Medicine Sales, 2018-2029
6.5.3 Germany Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.5.4 France Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.5.5 U.K. Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.5.6 Italy Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.5.7 Russia Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.5.8 Nordic Countries Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.5.9 Benelux Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Biological Pentylenediamine for Medicine Revenue, 2018-2029
6.6.2 By Region – Asia Biological Pentylenediamine for Medicine Sales, 2018-2029
6.6.3 China Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.6.4 Japan Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.6.5 South Korea Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.6.6 Southeast Asia Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.6.7 India Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Biological Pentylenediamine for Medicine Revenue, 2018-2029
6.7.2 By Country – South America Biological Pentylenediamine for Medicine Sales, 2018-2029
6.7.3 Brazil Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.7.4 Argentina Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Biological Pentylenediamine for Medicine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Biological Pentylenediamine for Medicine Sales, 2018-2029
6.8.3 Turkey Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.8.4 Israel Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.8.5 Saudi Arabia Biological Pentylenediamine for Medicine Market Size, 2018-2029
6.8.6 UAE Biological Pentylenediamine for Medicine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Cathay Biotech
7.1.1 Cathay Biotech Company Summary
7.1.2 Cathay Biotech Business Overview
7.1.3 Cathay Biotech Biological Pentylenediamine for Medicine Major Product Offerings
7.1.4 Cathay Biotech Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.1.5 Cathay Biotech Key News & Latest Developments
7.2 Aphena Pharma Solutions
7.2.1 Aphena Pharma Solutions Company Summary
7.2.2 Aphena Pharma Solutions Business Overview
7.2.3 Aphena Pharma Solutions Biological Pentylenediamine for Medicine Major Product Offerings
7.2.4 Aphena Pharma Solutions Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.2.5 Aphena Pharma Solutions Key News & Latest Developments
7.3 Bio-Tech Pharmacal
7.3.1 Bio-Tech Pharmacal Company Summary
7.3.2 Bio-Tech Pharmacal Business Overview
7.3.3 Bio-Tech Pharmacal Biological Pentylenediamine for Medicine Major Product Offerings
7.3.4 Bio-Tech Pharmacal Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.3.5 Bio-Tech Pharmacal Key News & Latest Developments
7.4 Goodwin Biotechnology
7.4.1 Goodwin Biotechnology Company Summary
7.4.2 Goodwin Biotechnology Business Overview
7.4.3 Goodwin Biotechnology Biological Pentylenediamine for Medicine Major Product Offerings
7.4.4 Goodwin Biotechnology Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.4.5 Goodwin Biotechnology Key News & Latest Developments
7.5 Xenon Pharmaceuticals
7.5.1 Xenon Pharmaceuticals Company Summary
7.5.2 Xenon Pharmaceuticals Business Overview
7.5.3 Xenon Pharmaceuticals Biological Pentylenediamine for Medicine Major Product Offerings
7.5.4 Xenon Pharmaceuticals Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.5.5 Xenon Pharmaceuticals Key News & Latest Developments
7.6 Nektar Therapeutics
7.6.1 Nektar Therapeutics Company Summary
7.6.2 Nektar Therapeutics Business Overview
7.6.3 Nektar Therapeutics Biological Pentylenediamine for Medicine Major Product Offerings
7.6.4 Nektar Therapeutics Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.6.5 Nektar Therapeutics Key News & Latest Developments
7.7 Midas Pharmaceuticals
7.7.1 Midas Pharmaceuticals Company Summary
7.7.2 Midas Pharmaceuticals Business Overview
7.7.3 Midas Pharmaceuticals Biological Pentylenediamine for Medicine Major Product Offerings
7.7.4 Midas Pharmaceuticals Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.7.5 Midas Pharmaceuticals Key News & Latest Developments
7.8 Kedrion Biopharma
7.8.1 Kedrion Biopharma Company Summary
7.8.2 Kedrion Biopharma Business Overview
7.8.3 Kedrion Biopharma Biological Pentylenediamine for Medicine Major Product Offerings
7.8.4 Kedrion Biopharma Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.8.5 Kedrion Biopharma Key News & Latest Developments
7.9 Xcelthera
7.9.1 Xcelthera Company Summary
7.9.2 Xcelthera Business Overview
7.9.3 Xcelthera Biological Pentylenediamine for Medicine Major Product Offerings
7.9.4 Xcelthera Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.9.5 Xcelthera Key News & Latest Developments
7.10 Anichem
7.10.1 Anichem Company Summary
7.10.2 Anichem Business Overview
7.10.3 Anichem Biological Pentylenediamine for Medicine Major Product Offerings
7.10.4 Anichem Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.10.5 Anichem Key News & Latest Developments
7.11 ALC Bio Innovations
7.11.1 ALC Bio Innovations Company Summary
7.11.2 ALC Bio Innovations Business Overview
7.11.3 ALC Bio Innovations Biological Pentylenediamine for Medicine Major Product Offerings
7.11.4 ALC Bio Innovations Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.11.5 ALC Bio Innovations Key News & Latest Developments
7.12 ACADIA Pharmaceuticals
7.12.1 ACADIA Pharmaceuticals Company Summary
7.12.2 ACADIA Pharmaceuticals Business Overview
7.12.3 ACADIA Pharmaceuticals Biological Pentylenediamine for Medicine Major Product Offerings
7.12.4 ACADIA Pharmaceuticals Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.12.5 ACADIA Pharmaceuticals Key News & Latest Developments
7.13 AbbVie
7.13.1 AbbVie Company Summary
7.13.2 AbbVie Business Overview
7.13.3 AbbVie Biological Pentylenediamine for Medicine Major Product Offerings
7.13.4 AbbVie Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.13.5 AbbVie Key News & Latest Developments
7.14 Ology Bioservices
7.14.1 Ology Bioservices Company Summary
7.14.2 Ology Bioservices Business Overview
7.14.3 Ology Bioservices Biological Pentylenediamine for Medicine Major Product Offerings
7.14.4 Ology Bioservices Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.14.5 Ology Bioservices Key News & Latest Developments
7.15 QMI – Quality Management
7.15.1 QMI – Quality Management Company Summary
7.15.2 QMI – Quality Management Business Overview
7.15.3 QMI – Quality Management Biological Pentylenediamine for Medicine Major Product Offerings
7.15.4 QMI – Quality Management Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.15.5 QMI – Quality Management Key News & Latest Developments
7.16 Biomiga
7.16.1 Biomiga Company Summary
7.16.2 Biomiga Business Overview
7.16.3 Biomiga Biological Pentylenediamine for Medicine Major Product Offerings
7.16.4 Biomiga Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.16.5 Biomiga Key News & Latest Developments
7.17 Molecular Targeting Technologies
7.17.1 Molecular Targeting Technologies Company Summary
7.17.2 Molecular Targeting Technologies Business Overview
7.17.3 Molecular Targeting Technologies Biological Pentylenediamine for Medicine Major Product Offerings
7.17.4 Molecular Targeting Technologies Biological Pentylenediamine for Medicine Sales and Revenue in Global (2018-2023)
7.17.5 Molecular Targeting Technologies Key News & Latest Developments
8 Global Biological Pentylenediamine for Medicine Production Capacity, Analysis
8.1 Global Biological Pentylenediamine for Medicine Production Capacity, 2018-2029
8.2 Biological Pentylenediamine for Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Biological Pentylenediamine for Medicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biological Pentylenediamine for Medicine Supply Chain Analysis
10.1 Biological Pentylenediamine for Medicine Industry Value Chain
10.2 Biological Pentylenediamine for Medicine Upstream Market
10.3 Biological Pentylenediamine for Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biological Pentylenediamine for Medicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Table 1. Key Players of Biological Pentylenediamine for Medicine in Global Market
Table 2. Top Biological Pentylenediamine for Medicine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Biological Pentylenediamine for Medicine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Biological Pentylenediamine for Medicine Revenue Share by Companies, 2018-2023
Table 5. Global Biological Pentylenediamine for Medicine Sales by Companies, (Tons), 2018-2023
Table 6. Global Biological Pentylenediamine for Medicine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Biological Pentylenediamine for Medicine Price (2018-2023) & (US$/Ton)
Table 8. Global Manufacturers Biological Pentylenediamine for Medicine Product Type
Table 9. List of Global Tier 1 Biological Pentylenediamine for Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biological Pentylenediamine for Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Biological Pentylenediamine for Medicine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Biological Pentylenediamine for Medicine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Biological Pentylenediamine for Medicine Sales (Tons), 2018-2023
Table 15. By Type - Global Biological Pentylenediamine for Medicine Sales (Tons), 2024-2029
Table 16. By Application – Global Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Biological Pentylenediamine for Medicine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Biological Pentylenediamine for Medicine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Biological Pentylenediamine for Medicine Sales (Tons), 2018-2023
Table 20. By Application - Global Biological Pentylenediamine for Medicine Sales (Tons), 2024-2029
Table 21. By Region – Global Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Biological Pentylenediamine for Medicine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Biological Pentylenediamine for Medicine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Biological Pentylenediamine for Medicine Sales (Tons), 2018-2023
Table 25. By Region - Global Biological Pentylenediamine for Medicine Sales (Tons), 2024-2029
Table 26. By Country - North America Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Biological Pentylenediamine for Medicine Sales, (Tons), 2018-2023
Table 29. By Country - North America Biological Pentylenediamine for Medicine Sales, (Tons), 2024-2029
Table 30. By Country - Europe Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Biological Pentylenediamine for Medicine Sales, (Tons), 2018-2023
Table 33. By Country - Europe Biological Pentylenediamine for Medicine Sales, (Tons), 2024-2029
Table 34. By Region - Asia Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Biological Pentylenediamine for Medicine Sales, (Tons), 2018-2023
Table 37. By Region - Asia Biological Pentylenediamine for Medicine Sales, (Tons), 2024-2029
Table 38. By Country - South America Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Biological Pentylenediamine for Medicine Sales, (Tons), 2018-2023
Table 41. By Country - South America Biological Pentylenediamine for Medicine Sales, (Tons), 2024-2029
Table 42. By Country - Middle East & Africa Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Biological Pentylenediamine for Medicine Sales, (Tons), 2018-2023
Table 45. By Country - Middle East & Africa Biological Pentylenediamine for Medicine Sales, (Tons), 2024-2029
Table 46. Cathay Biotech Company Summary
Table 47. Cathay Biotech Biological Pentylenediamine for Medicine Product Offerings
Table 48. Cathay Biotech Biological Pentylenediamine for Medicine Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 49. Cathay Biotech Key News & Latest Developments
Table 50. Aphena Pharma Solutions Company Summary
Table 51. Aphena Pharma Solutions Biological Pentylenediamine for Medicine Product Offerings
Table 52. Aphena Pharma Solutions Biological Pentylenediamine for Medicine Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 53. Aphena Pharma Solutions Key News & Latest Developments
Table 54. Bio-Tech Pharmacal Company Summary
Table 55. Bio-Tech Pharmacal Biological Pentylenediamine for Medicine Product Offerings
Table 56. Bio-Tech Pharmacal Biological Pentylenediamine for Medicine Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 57. Bio-Tech Pharmacal Key News & Latest Developments
Table 58. Goodwin Biotechnology Company Summary
Table 59. Goodwin Biotechnology Biological Pentylenediamine for Medicine Product Offerings
Table 60. Goodwin Biotechnology Biological Pentylenediamine for Medicine Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 61. Goodwin Biotechnology Key News & Latest Developments
Table 62. Xenon Pharmaceuticals Company Summary
Table 63. Xenon Pharmaceuticals Biological Pentylenediamine for Medicine Product Offerings
Table 64. Xenon Pharmaceuticals Biological Pentylenediamine for Medicine Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 65. Xenon Pharmaceuticals Key News & Latest Developments
Table 66. Nektar Therapeutics Company Summary
Table 67. Nektar Therapeutics Biological Pentylenediamine for Medicine Product Offerings
Table 68. Nektar Therapeutics Biological Pentylenediamine for Medicine Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 69. Nektar Therapeutics Key News & Latest Developments
Table 70. Midas Pharmaceuticals Company Summary
Table 71. Midas Pharmaceuticals Biological Pentylenediamine for Medicine Product Offerings
Table 72. Midas Pharmaceuticals Biological Pentylenediamine for Medicine Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 73. Midas Pharmaceuticals Key News & Latest Developments
Table 74. Kedrion Biopharma Company Summary
Table 75. Kedrion Biopharma Biological Pentylenediamine for Medicine Product Offerings
Table 76. Kedrion Biopharma Biological Pentylenediamine for Medicine Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 77. Kedrion Biopharma Key News & Latest Developments
Table 78. Xcelthera Company Summary
Table 79. Xcelthera Biological Pentylenediamine for Medicine Product Offerings
Table 80. Xcelthera Biological Pentylenediamine for Medicine Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 81. Xcelthera Key News & Latest Developments
Table 82. Anichem Company Summary
Table 83. Anichem Biological Pentylenediamine for Medicine Product Offerings
Table 84. Anichem Biological Pentylenediamine for Medicine Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 85. Anichem Key News & Latest Developments
Table 86. ALC Bio Innovations Company Summary
Table 87. ALC Bio Innovations Biological Pentylenediamine for Medicine Product Offerings
Table 88. ALC Bio Innovations Biological Pentylenediamine for Medicine Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 89. ALC Bio Innovations Key News & Latest Developments
Table 90. ACADIA Pharmaceuticals Company Summary
Table 91. ACADIA Pharmaceuticals Biological Pentylenediamine for Medicine Product Offerings
Table 92. ACADIA Pharmaceuticals Biological Pentylenediamine for Medicine Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 93. ACADIA Pharmaceuticals Key News & Latest Developments
Table 94. AbbVie Company Summary
Table 95. AbbVie Biological Pentylenediamine for Medicine Product Offerings
Table 96. AbbVie Biological Pentylenediamine for Medicine Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 97. AbbVie Key News & Latest Developments
Table 98. Ology Bioservices Company Summary
Table 99. Ology Bioservices Biological Pentylenediamine for Medicine Product Offerings
Table 100. Ology Bioservices Biological Pentylenediamine for Medicine Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 101. Ology Bioservices Key News & Latest Developments
Table 102. QMI - Quality Management Company Summary
Table 103. QMI - Quality Management Biological Pentylenediamine for Medicine Product Offerings
Table 104. QMI - Quality Management Biological Pentylenediamine for Medicine Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 105. QMI - Quality Management Key News & Latest Developments
Table 106. Biomiga Company Summary
Table 107. Biomiga Biological Pentylenediamine for Medicine Product Offerings
Table 108. Biomiga Biological Pentylenediamine for Medicine Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 109. Biomiga Key News & Latest Developments
Table 110. Molecular Targeting Technologies Company Summary
Table 111. Molecular Targeting Technologies Biological Pentylenediamine for Medicine Product Offerings
Table 112. Molecular Targeting Technologies Biological Pentylenediamine for Medicine Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 113. Molecular Targeting Technologies Key News & Latest Developments
Table 114. Biological Pentylenediamine for Medicine Production Capacity (Tons) of Key Manufacturers in Global Market, 2021-2023 (Tons)
Table 115. Global Biological Pentylenediamine for Medicine Capacity Market Share of Key Manufacturers, 2021-2023
Table 116. Global Biological Pentylenediamine for Medicine Production by Region, 2018-2023 (Tons)
Table 117. Global Biological Pentylenediamine for Medicine Production by Region, 2024-2029 (Tons)
Table 118. Biological Pentylenediamine for Medicine Market Opportunities & Trends in Global Market
Table 119. Biological Pentylenediamine for Medicine Market Drivers in Global Market
Table 120. Biological Pentylenediamine for Medicine Market Restraints in Global Market
Table 121. Biological Pentylenediamine for Medicine Raw Materials
Table 122. Biological Pentylenediamine for Medicine Raw Materials Suppliers in Global Market
Table 123. Typical Biological Pentylenediamine for Medicine Downstream
Table 124. Biological Pentylenediamine for Medicine Downstream Clients in Global Market
Table 125. Biological Pentylenediamine for Medicine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biological Pentylenediamine for Medicine Segment by Type in 2022
Figure 2. Biological Pentylenediamine for Medicine Segment by Application in 2022
Figure 3. Global Biological Pentylenediamine for Medicine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biological Pentylenediamine for Medicine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Biological Pentylenediamine for Medicine Revenue, 2018-2029 (US$, Mn)
Figure 7. Biological Pentylenediamine for Medicine Sales in Global Market: 2018-2029 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Biological Pentylenediamine for Medicine Revenue in 2022
Figure 9. By Type - Global Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Biological Pentylenediamine for Medicine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Biological Pentylenediamine for Medicine Sales Market Share, 2018-2029
Figure 12. By Type - Global Biological Pentylenediamine for Medicine Price (US$/Ton), 2018-2029
Figure 13. By Application - Global Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Biological Pentylenediamine for Medicine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Biological Pentylenediamine for Medicine Sales Market Share, 2018-2029
Figure 16. By Application - Global Biological Pentylenediamine for Medicine Price (US$/Ton), 2018-2029
Figure 17. By Region - Global Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Biological Pentylenediamine for Medicine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Biological Pentylenediamine for Medicine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Biological Pentylenediamine for Medicine Sales Market Share, 2018-2029
Figure 21. By Country - North America Biological Pentylenediamine for Medicine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Biological Pentylenediamine for Medicine Sales Market Share, 2018-2029
Figure 23. US Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Biological Pentylenediamine for Medicine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Biological Pentylenediamine for Medicine Sales Market Share, 2018-2029
Figure 28. Germany Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 29. France Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Biological Pentylenediamine for Medicine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Biological Pentylenediamine for Medicine Sales Market Share, 2018-2029
Figure 37. China Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 41. India Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Biological Pentylenediamine for Medicine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Biological Pentylenediamine for Medicine Sales Market Share, 2018-2029
Figure 44. Brazil Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Biological Pentylenediamine for Medicine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Biological Pentylenediamine for Medicine Sales Market Share, 2018-2029
Figure 48. Turkey Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Biological Pentylenediamine for Medicine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Biological Pentylenediamine for Medicine Production Capacity (Tons), 2018-2029
Figure 53. The Percentage of Production Biological Pentylenediamine for Medicine by Region, 2022 VS 2029
Figure 54. Biological Pentylenediamine for Medicine Industry Value Chain
Figure 55. Marketing Channels
• 日本語訳：世界の医療用生物学的ペンチレンジアミン市場予測2023-2029：純度98.5%-99%、純度≧99%
• レポートコード：MRC2312MG03409 ▷ お問い合わせ（見積依頼・ご注文・質問）